静脉-静脉体外膜氧合「清醒」插管:体外生命支持组织登记数据分析
该研究分析体外生命支持组织(ELSO)多中心前瞻性登记中2016至2022年接受静脉-静脉ECMO的18岁及以上患者,比较「清醒」插管(插管过程中保持自主呼吸、不做有创机械通气)与机械通气下插管的结局。共纳入28,627例,其中797例(2.8%)为清醒插管。清醒插管者年龄更大(52.2岁 vs 47.8岁),慢性肺病(50.6% vs 48.9%)和缺血性心脏病(4.3% vs 2.7%)患病率更高。倾向评分匹配后,两组出院存活无显著差异(清醒插管组存活率提高2.4%,95%CI -1.7%至6.4%,P=0.26)。作者认为未来研究应聚焦于识别最可能从清醒插管获益的患者人群。
要点
- 静脉-静脉ECMO清醒插管在ELSO登记中占2.8%(797/28,627),2016至2022年间使用逐渐增多。
- 清醒插管者较机械通气下插管者年龄更大(52.2岁 vs 47.8岁),慢性肺病(50.6% vs 48.9%)与缺血性心脏病(4.3% vs 2.7%)更多。
- 倾向评分匹配后,清醒插管组出院存活率较非清醒组提高2.4%(95%CI -1.7%至6.4%,P=0.26),未达统计学显著。
- 作者认为未来研究应聚焦于识别最可能从「清醒」插管获益的患者人群。
适用人群与场景
- 2016至2022年间在体外生命支持组织(ELSO)多中心登记中接受静脉-静脉ECMO插管的18岁及以上患者。
处置流程与药物剂量
- 「清醒」插管指插管过程中患者保持自主呼吸、不做有创机械通气。
研究设计与关键结果
- 研究类型为对体外生命支持组织(ELSO)多中心前瞻性登记的分析,纳入28,627例接受静脉-静脉ECMO的患者,其中797例(2.8%)接受清醒插管。
- 清醒插管组与机械通气下插管组比较:年龄52.2岁 vs 47.8岁;慢性肺病50.6% vs 48.9%;缺血性心脏病4.3% vs 2.7%。
- 倾向评分匹配后,清醒插管组出院存活率较非清醒插管组提高2.4%(95%CI -1.7%至6.4%,P=0.26),两组出院存活无显著差异。
- 清醒插管在静脉-静脉ECMO中不常见,但随时间推移使用逐渐增多。
证据类型、等级与局限
- 证据类型:基于多中心前瞻性登记(ELSO)的分析;原文未报告证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为未来研究应聚焦于识别最可能从「清醒」插管获益的患者人群。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: "Awake" cannulation for venovenous extracorporeal membrane oxygenation (ECMO), where patients remain spontaneously breathing without invasive mechanical ventilation during the cannulation procedure, may reduce lung injury from positive pressure ventilation and promote patient mobility.
OBJECTIVES: To examine the association between "awake" cannulation for venovenous ECMO and patient outcomes.
DESIGN, SETTING, AND PARTICIPANTS: Analysis of the prospectively collected by the multicenter Extracorporeal Life Support Organization registry. Patients 18 years old or older who were cannulated for venovenous ECMO between 2016 and 2022 were included.
MAIN OUTCOMES AND MEASURES: Propensity score matching techniques were used to examine the association between the primary exposure of "awake" cannulation and the primary outcome of hospital mortality.
RESULTS: This study analyzed data from 28,627 patients who received venovenous ECMO, including 797 (2.8%) who underwent awake cannulation. Patients undergoing awake cannulation were older (52.2 vs. 47.8 yr), had greater prevalence of chronic lung diseases (50.6% vs. 48.9%), and ischemic heart disease (4.3% vs. 2.7%) compared with those cannulated while receiving mechanical ventilation. Hospital survival to discharge was did not differ significantly between awake and nonawake cannulation groups after propensity score matching (2.4% increased rate of survival for patients cannulated awake; 95% CI, -1.7% to 6.4%; p = 0.26).
CONCLUSIONS AND RELEVANCE: In this large, multicenter study, awake cannulation for venovenous ECMO was uncommon but increasingly used over time. Survival to hospital discharge was similar to patients cannulated while on mechanical ventilation. Future research should focus on identification of patient cohorts most likely to benefit from ""awake" cannulation.
参考来源
- Mohamed A, Saeed O, Fazzari M, et al. "Awake" Cannulation of Patients for Venovenous Extracorporeal Membrane Oxygen: An Analysis of the Extracorporeal Life Support Organization Registry. Crit Care Explor. 2024. PMID: 39569980. doi:10.1097/CCE.0000000000001181
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。